Pharmaceutical Executive March 5, 2021
Dr. Amy P. Abernethy talks about her career moves from academia to industry to the US Food & Drug Administration.
Michael Wong speaks to Dr. Amy P. Abernethy about making the transition from oncologist to the Agency’s Principal Deputy Commissioner/Acting CIO of FDA.
Michael Wong: While some of my friends have moved from academia to industry, like you did as a Professor at Duke University to a C-Suite role at Flatiron Health, why did you join FDA and what were the key steps to make this transition?
Amy Abernethy: While my career has evolved across settings, my core focus has not changed: how do we improve the care of the patient sitting in front of me, especially by learning from...